Dysregulated expression or mutation of TP53 which finally leads to abnormal cell function could enhance the aggressive nature of RAFLS or autoreactivity in lymphocytes and leads to the inflammatory phenotype in RA joints.52 This evidence concerns the gene TP53 and rheumatoid arthritis.